<--- Back to Details
First PageDocument Content
Health / Biology / Lower respiratory tract infection / Community-acquired pneumonia / Chlamydophila pneumoniae / Hospital-acquired pneumonia / Pneumococcal infection / Nosocomial infection / Mycoplasma pneumonia / Pneumonia / Infectious diseases / Medicine
Date: 1999-11-25 18:44:26
Health
Biology
Lower respiratory tract infection
Community-acquired pneumonia
Chlamydophila pneumoniae
Hospital-acquired pneumonia
Pneumococcal infection
Nosocomial infection
Mycoplasma pneumonia
Pneumonia
Infectious diseases
Medicine

Add to Reading List

Source URL: erj.ersjournals.com

Download Document from Source Website

File Size: 134,77 KB

Share Document on Facebook

Similar Documents

Pneumonia / Bacteria / Microbiology / Medicine / Pneumococcal pneumonia / Antimicrobial resistance / Streptococcus pneumoniae / Pneumococcal infection / Bacterial pneumonia

LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held

DocID: 1rhtI - View Document

Medicine / Pneumonia / Vaccines / Clinical medicine / Microbiology / Vaccination / RTT / Pneumococcal polysaccharide vaccine / Pneumococcal vaccine / Pneumococcal infection / Asplenia / Streptococcus pneumoniae

HIN Logo_Color_Master_Standard Logo_CS2

DocID: 1qGRg - View Document

Vaccines / Medicine / Clinical medicine / Vaccination / Pneumonia / RTT / Pneumococcal polysaccharide vaccine / Bacterial diseases / Pneumococcal vaccine / Pneumococcal infection / Meningitis / Pneumococcal pneumonia

ppsv - what you need to know- 508 compliant

DocID: 1q1Yu - View Document

Bacterial diseases / Pneumonia / Antibiotics / Infectious diseases / Antimicrobial resistance / Pharmaceuticals policy / Pneumococcal pneumonia / Infection / Omadacycline / Pneumococcal infection

Combioxin receives Clinical Trial Authorization to initiate a first-in-man study with CAL02 in patients with severe pneumococcal pneumonia GENEVA, SWITZERLAND, 12 January 2016 – Combioxin SA is pleased to announce that

DocID: 1prxw - View Document

Polysaccharide encapsulated bacteria / Acute pain / Meningitis / Pathogenic bacteria / Pneumonia / Viral meningitis / Neisseria meningitidis / Streptococcus pneumoniae / Listeria monocytogenes / Encephalitis / Pneumococcal infection / Streptococcus agalactiae

BATTLING INFECTIONS OF THE CENTRAL NERVOUS SYSTEM Organisms, Risk Factors, and Laboratory Diagnostics Blake W. Buchan, PhD, D(ABMM) Email: Phone:

DocID: 1oWg5 - View Document